Stephen Mok

The University of Texas MD Anderson Cancer Center — United States

Immunology and Microbiology · Life Sciences

18h-index4.6kcitations117works10.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune cells in cancer(41), Cancer Immunotherapy and Biomarkers(38), CAR-T cell therapy research(35), Immunotherapy and Immune Responses(34), Melanoma and MAPK Pathways(28)

Publications117 total

Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1
Proceedings of the National Academy of Sciences·2025· 16 citedOpen Access
Post-immunotherapy CTLA-4 Ig treatment improves antitumor efficacy
Proceedings of the National Academy of Sciences·2024· 15 citedOpen Access
Abstract 1354: Anti-CTLA-4 generates memory T-cells with greater expansion and functionality than anti-PD-1
Cancer Research·2024
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors
Journal of Clinical Investigation·2023· 3 citedOpen Access
Abstract A054: Anti-CTLA-4 generates memory T-cell with greater expansion and functionality than anti-PD-1
Cancer Immunology Research·2023
IMMUNOPATHOLOGY OF DIABETES MELLITUS IN PULMONARY TUBERCULOSIS IS DRIVEN BY NEUTROPHIL HYPER-INFLAMMATORY DYSFUNCTION: DATA FROM A CELLULAR MODEL AND HUMAN COHORT.
International Journal of Infectious Diseases·2023Open Access
Abstract 4149: Anti-CTLA-4 generates memory T-cells with greater expansion and functionality than anti-PD-1
Cancer Research·2023
Supplementary Figure 1 from CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
2023Open Access
Data from CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans
2023Open Access
Data from CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
2023Open Access
Supplementary Figure 1 from CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
2023Open Access
Supplementary Figure 2 from CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
2023Open Access
Supplementary Figure Legends, Tables 1 - 3 from CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
2023Open Access
Data from CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
2023Open Access
Supplementary Figure 2 from CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans
2023Open Access
Supplementary Figure 2 from CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans
2023Open Access
Supplementary Figure 1 from CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans
2023Open Access
Supplementary Figure 1 from CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans
2023Open Access
Supplementary Figure Legends, Tables 1 - 3 from CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
2023Open Access
Data from CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Antoni Ribas(36), Richard C. Koya(29), Thomas G. Graeber(19), Begonya Comin-Anduix(12), Thinle Chodon(11), Lídia Robert(10), James P. Allison(10), Paul C. Tumeh(9), Nicholas Otte(8), Gideon Bollag(7), Kevin J. Blacketor(7), Aspram Minasyan(7), Nicholas A. Graham(7), Colm R. Duffy(7), Begoña Comı́n-Anduix(6), Brian L. West(6), Bartosz Chmielowski(5), Grant A. McArthur(5), Jennifer Tsoi(5), Jingying Xu(5)